KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Capital Expenditures (2016 - 2026)

Medtronic (MDT) has disclosed Capital Expenditures for 13 consecutive years, with $444.0 million as the latest value for Q1 2026.

  • Quarterly Capital Expenditures fell 6.72% to $444.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.9 billion through Jan 2026, up 2.68% year-over-year, with the annual reading at $1.9 billion for FY2025, 17.14% up from the prior year.
  • Capital Expenditures hit $444.0 million in Q1 2026 for Medtronic, down from $468.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $520.0 million in Q3 2024 to a low of $323.0 million in Q4 2022.
  • Historically, Capital Expenditures has averaged $414.1 million across 5 years, with a median of $426.0 million in 2022.
  • Biggest five-year swings in Capital Expenditures: fell 16.9% in 2023 and later skyrocketed 46.89% in 2024.
  • Year by year, Capital Expenditures stood at $323.0 million in 2022, then soared by 42.72% to $461.0 million in 2023, then dropped by 12.36% to $404.0 million in 2024, then rose by 15.84% to $468.0 million in 2025, then dropped by 5.13% to $444.0 million in 2026.
  • Business Quant data shows Capital Expenditures for MDT at $444.0 million in Q1 2026, $468.0 million in Q4 2025, and $504.0 million in Q3 2025.